Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_assertion type Assertion NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_head.
- NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_assertion description "[Among these cancers are chronic neutrophilic leukemia (CNL) and atypical (BCR-ABL1-negative) chronic myeloid leukemia (CML), both of which are diagnosed on the basis of neoplastic expansion of granulocytic cells and exclusion of genetic drivers that are known to occur in other myeloproliferative neoplasms and myeloproliferative-myelodysplastic overlap neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_provenance.
- NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_assertion evidence source_evidence_literature NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_provenance.
- NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_assertion SIO_000772 23656643 NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_provenance.
- NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_assertion wasDerivedFrom befree-2016 NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_provenance.
- NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_assertion wasGeneratedBy ECO_0000203 NP1076020.RAgVJbhU1fwZLOKBdF8UwI0U7NdlaU0s-bqJiYeS5do3M130_provenance.